CYTOVATION ASA: årsregnskap 2024 vs 2023
Stronger earnings, cash halved-plus
approved 2025-06-03; registry 2025-07-21; journal 2025 688543
Summary
What changed
Comparing Årsregnskap 2024 with 2023 for CYTOVATION ASA. Net result -81.51m NOK → -62.90m NOK. Equity -30.44m NOK → -93.33m NOK.
On the constructive side: operating result improved; net result improved. Pressures included: equity eroded; cash fell.
Also worth watching: thin equity buffer; sharp cash drawdown. All figures are taken from the published annual accounts for CYTOVATION ASA.
At a glance
Scorecard
What improved
-
↑
Operating result improved
Operating result -77.25m NOK → -54.81m NOK. Calculated
-
↑
Net result improved
Net result -81.51m NOK → -62.90m NOK. Calculated
What deteriorated
-
↓
Equity eroded
Book equity -30.44m NOK → -93.33m NOK (equity ratio -38.9% → -591.5%). Calculated
-
↓
Cash fell
Bank deposits 70.21m NOK → 7.25m NOK (-89.7% YoY). Calculated
Things to notice
-
·
Thin equity buffer
Equity ratio is -591.5% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation
-
·
Sharp cash drawdown
Cash fell by more than 60% YoY (70.21m NOK → 7.25m NOK). Check whether funds moved to group receivables, investments, or operating burn. Interpretation